Skip to main content
SpringerLink
Log in

Kardiovaskuläre Auswirkungen hormoneller Kontrazeption

Cardiovascular effects of hormonal contraception

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

An Erratum to this article was published on 22 February 2014

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Lidegaard Ø, Nielsen LH, Skovlund CW, Lokkegaard E (2012) Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ 344:e2990

    Article  PubMed Central  PubMed  Google Scholar 

  2. Lidegaard Ø, Nielsen LH, Skovlund CW et al (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ 343:d6423

    Article  PubMed Central  PubMed  Google Scholar 

  3. Severinsen MT, Kristensen SR, Overvad K et al (2010) Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 63:223–228

    Google Scholar 

  4. Sherif K (1999) Benefits and risks of oral contraceptives. Am J Obstet Gynecol 180(6 Suppl):S343–S348

    Article  CAS  PubMed  Google Scholar 

  5. Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333

    Article  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. J. Dinger war Studienleiter zahlreicher epidemiologischer Studien; darunter Studien, die von Herstellern hormoneller Kontrazeptiva finanziert und von unabhängigen Gremien überwacht wurden. Er hat mit dem Erstautor der kommentierten Studie mehrere öffentliche Diskussionen über methodologische Probleme in epidemiologischen Studien geführt. S. Nitschmann gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Zentrum für Epidemiologie und Gesundheitsforschung Berlin, Invalidenstr. 115, 10115, Berlin, Deutschland

    J. Dinger

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. J. Dinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Dinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dinger, J., Nitschmann, S. Kardiovaskuläre Auswirkungen hormoneller Kontrazeption. Internist 54, 1520–1522 (2013). https://doi.org/10.1007/s00108-013-3394-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-013-3394-5

Search

Navigation